For: | 黄健翔, 骆旭航, 龚安安. 卡瑞利珠单抗配合TACE对伴微血管侵犯肝细胞癌患者根治术后血清Egfl7、VEGF、OPN水平及复发率影响的前瞻性研究. 世界华人消化杂志 2021; 29(4): 182-189 [DOI: 10.11569/wcjd.v29.i4.182] |
---|---|
URL: | https://www.wjgnet.com/1009-3079/full/v29/i4/182.htm |
编号 | Citing Articles |
1 |
Qing Yang, Gengyu Li, Xiaoqiu Wu, Haiying Lin, Wanrui Wu, Xiangpang Xie, Yu Zhu, Wei Cai, Changsheng Shi, Shengye Zhuo. RETRACTED: A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1136366
|
2 |
Sujing Zhang, Yingchun Zhao, Li He, Changwen Bo, Yonghui An, Na Li, Wenhua Ma, Ying Guo, Yan Guo, Changwang Zhang. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2022; 46(4): 101851 doi: 10.1016/j.clinre.2021.101851
|